ITU Unit Action

ESBRIET (PIRFENIDONE) INSPIRATION PROGRAM

GENENTECH, INC.

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	86760348	FILING DATE	09/17/2015
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	MARTIN, LIEF ANDREW	L.O. ASSIGNED	112

PUB INFORMATION
RUN DATE	06/18/2019
PUB DATE	05/03/2016
STATUS	748-STATEMENT OF USE - TO EXAMINER
STATUS DATE	06/17/2019
LITERAL MARK ELEMENT	ESBRIET (PIRFENIDONE) INSPIRATION PROGRAM

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	NO
LITERAL MARK ELEMENT	ESBRIET (PIRFENIDONE) INSPIRATION PROGRAM
MARK DRAWING CODE	3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	GENENTECH, INC.
ADDRESS	1 DNA WAY SOUTH SAN FRANCISCO, CA 940804990
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

GOODS AND SERVICES
INTERNATIONAL CLASS	016
DESCRIPTION TEXT	Printed materials, namely, brochures in the field of idiopathic pulmonary fibrosis

INTERNATIONAL CLASS	035
DESCRIPTION TEXT	Administration services, namely, managing a database of patient information for others; operation of telephone call centers for others

INTERNATIONAL CLASS	041
DESCRIPTION TEXT	Educational services, namely, providing classes, seminars, and lectures, all in the field of the diagnosis and treatment of idiopathic pulmonary fibrosis

INTERNATIONAL CLASS	044
DESCRIPTION TEXT	Information services in the field of diagnosing and treating idiopathic pulmonary fibrosis

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	016	FIRST USE DATE	10/22/2015	FIRST USE IN COMMERCE DATE	10/22/2015	CLASS STATUS	6-ACTIVE

INTERNATIONAL CLASS	035	FIRST USE DATE	09/08/2015	FIRST USE IN COMMERCE DATE	09/08/2015	CLASS STATUS	6-ACTIVE

INTERNATIONAL CLASS	041	FIRST USE DATE	10/22/2015	FIRST USE IN COMMERCE DATE	10/22/2015	CLASS STATUS	6-ACTIVE

INTERNATIONAL CLASS	044	FIRST USE DATE	10/22/2015	FIRST USE IN COMMERCE DATE	10/22/2015	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO
COLORS CLAIMED STATEMENT	Color is not claimed as a feature of the mark.
DISCLAIMER W/PREDETER TXT	"PIRFENIDONE" AND "PROGRAM"
DESCRIPTION OF MARK	The mark consists of the wording "ESBRIET (PIRFENIDONE) INSPIRATION PROGRAM" appearing to the right of a square turned 45 degrees with lines inside the square meeting at the center forming triangles.

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
06/17/2019	SUPC	I	STATEMENT OF USE PROCESSING COMPLETE	039
06/14/2019	IUAF	S	USE AMENDMENT FILED	038
06/14/2019	EISU	I	TEAS STATEMENT OF USE RECEIVED	037
11/10/2018	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	036
11/09/2018	EX5G	S	EXTENSION 5 GRANTED	035
11/05/2018	EXT5	S	EXTENSION 5 FILED	034
11/09/2018	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	033
11/05/2018	EEXT	I	TEAS EXTENSION RECEIVED	032
05/26/2018	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	031
05/24/2018	EX4G	S	EXTENSION 4 GRANTED	030
05/24/2018	EXT4	S	EXTENSION 4 FILED	029
05/24/2018	EEXT	I	TEAS EXTENSION RECEIVED	028
11/11/2017	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	027
11/09/2017	EX3G	S	EXTENSION 3 GRANTED	026
11/09/2017	EXT3	S	EXTENSION 3 FILED	025
11/09/2017	EEXT	I	TEAS EXTENSION RECEIVED	024
06/23/2017	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	023
06/21/2017	EX2G	S	EXTENSION 2 GRANTED	022
06/21/2017	EXT2	S	EXTENSION 2 FILED	021
06/21/2017	EEXT	I	TEAS EXTENSION RECEIVED	020
12/23/2016	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	019
12/21/2016	EX1G	S	EXTENSION 1 GRANTED	018
12/21/2016	EXT1	S	EXTENSION 1 FILED	017
12/21/2016	EEXT	I	TEAS EXTENSION RECEIVED	016
06/28/2016	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	015
05/03/2016	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	014
05/03/2016	PUBO	A	PUBLISHED FOR OPPOSITION	013
04/13/2016	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	012
03/16/2016	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	011
03/16/2016	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	010
03/15/2016	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	009
03/15/2016	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	008
12/02/2015	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	007
12/02/2015	GNRT	F	NON-FINAL ACTION E-MAILED	006
12/02/2015	CNRT	R	NON-FINAL ACTION WRITTEN	005
12/02/2015	DOCK	D	ASSIGNED TO EXAMINER	004
09/23/2015	MDSC	E	NOTICE OF DESIGN SEARCH CODE E-MAILED	003
09/22/2015	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
09/21/2015	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	NONE
CORRESPONDENCE ADDRESS	GENENTECH, INC. 1 Dna Way South San Francisco, CA 94080-4918
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	GENENTECH, INC.
ADDRESS	1 DNA WAY SOUTH SAN FRANCISCO, CA 940804990
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

ITU Unit Action [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.